Serato, Antonio C.

HRN: 00-66-80  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/20/2024
03/13/2024
IV
4.5gram
Q8H
CAP-HR
Waiting Final Action 
02/20/2024
MUPIROCIN 2%, 15G (TUBE)
02/20/2024
02/27/2024
TOPICAL
Apply Thin
BID
Decubitus Ulcer
Waiting Final Action 
02/22/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/22/2024
02/29/2024
IV
1.5gms
Q6
Infected Wound
Waiting Final Action 
02/22/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/22/2024
02/29/2024
IV
600mg
Q6
Infected Wound
Waiting Final Action 
02/27/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/27/2024
03/05/2024
IV
4.5g
Q6hr For 7 More Days
CAP-MR
Waiting Final Action 
03/07/2024
LEVOFLOXACIN 500MG (TAB)
03/07/2024
03/13/2024
ORAL
500mg
OD
CAP MR
Waiting Final Action 
03/14/2024
CEFTAZIDIME 1GM (VIAL)
03/14/2024
03/21/2024
IVT
1g
Q8
CAP HR; Pleural Effusion Left
Waiting Final Action 
03/27/2024
MUPIROCIN 2%, 15G (TUBE)
03/27/2024
04/03/2024
TOPICAL
2%
BID
Decubitus Ulcer
Waiting Final Action 
04/01/2024
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
04/01/2024
04/15/2024
TOPICAL
20mg
BID
Decubitus Ulcer
Waiting Final Action 
04/10/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/10/2024
04/16/2024
IVTT
600mg
Q8
Infected Wound, Pressure Ulcer
Waiting Final Action 
04/10/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/10/2024
04/16/2024
IVTT
1.5 G
Q6
Cap-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: